A worldwide consortium of 87 studies on leukocyte telomere length (LTL) and noncommunicable diseases such as diabetes type 2 and cardiovascular disease is set up. This initiative is necessary to further disentangle the association between LTL and health and disease. Because of the large inter individual variation in LTL large sample sizes are a prerequisite.
The strength of this initiative is that it comprises over 140.000 individuals. This consortium initiative also offers the opportunity to investigate the association between telomere attrition, for which a longitudinal design is required, and noncommunicable diseases.